Resistance of young gelatinase B–deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions
Open Access
- 1 December 1999
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 104 (11) , 1507-1515
- https://doi.org/10.1172/jci6886
Abstract
Regulated expression of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) plays a role in various physiological processes. To determine in vivo how unbalanced expression of these factors can promote or affect the course of pathologies, we knocked out the mouse gelatinase B gene by replacing the catalytic and zinc-binding domains with an antisense-oriented neomycin resistance gene. Adult gelatinase B–deficient mice and wild-type controls could be induced to develop experimental autoimmune encephalomyelitis (EAE) with similar scores for neurologic disease, blood-brain barrier permeability, and central nervous system histopathology. However, whereas diseased control animals showed necrotizing tail lesions with hyperplasia of osteocartilaginous tissue, adult gelatinase B–deficient mice were resistant to this tail pathology. Gelatinase B–deficient mice younger than 4 weeks of age were significantly less susceptible to the development of EAE than were age matched controls and, even as they aged, they remained resistant to tail lesions. These data illustrate that gelatinase B expression plays a role in the development of the immune system and that, in ontogenesis, the propensity to develop autoimmunity is altered by the absence of this MMP. J. Clin. Invest.104:1507–1515 (1999).Keywords
This publication has 59 references indexed in Scilit:
- Gelatinase B–deficient Mice Are Resistant to Experimental Bullous PemphigoidThe Journal of Experimental Medicine, 1998
- Matrix metalloproteinase 9 level predicts optimal collagen deposition during early wound repair in humansBritish Journal of Surgery, 1998
- Mighty mice: Transgenic technology “knocks out” questions of matrix metalloproteinase functionMatrix Biology, 1997
- Matrix Metalloproteinase Expression During Mouse Peri‐implantation DevelopmentAmerican Journal of Reproductive Immunology, 1996
- Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamineInflammation Research, 1995
- Animal models of human disease Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating diseaseClinical Immunology and Immunopathology, 1995
- Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790Inflammation Research, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Cytokine-regulated proteases in autoimmune diseasesImmunology Today, 1994
- Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic ProteinBiochemical and Biophysical Research Communications, 1993